The pill, branded as Lipfendra, is intended to treat patients with hypercholesterolemia, including those with hereditary ...

Patients who need to lower their cholesterol will soon have a powerful new option. On Thursday, the Food and Drug ...

Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.

A significant breakthrough in heart disease prevention arrived on July 16, 2026, with the FDA approval of Lipfendra ...

Lipfendra (enlicitide) is the first PCSK9 inhibitor in a pill, and can help get LDL ‘bad’ cholesterol in check when statins ...

The drug is the first oral form of a class of powerful cholesterol-fighting drugs called PCSK9 inhibitors.

The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.

The FDA approved enlicitide (Lipfendra; Merck), the first oral PCSK9 inhibitor for lowering low-density lipoprotein ...

The Edmonton Oilers Community Foundation (EOCF) life changing 50/50 raffle is back! As the largest 50/50 raffle in professional sports, fans in Alberta will have the chance to win big all season long.

Meet our inaugural class of entrepreneurs, leaders, scientists and creators who, after the age of 50, are achieving their greatest accomplishments and making their biggest impact. Together, they ...

There comes a point in every woman’s life where losing weight becomes harder than it used to be—that’s just a fact. Weight loss after 50 takes a lot of consistency, commitment, motivation, and ...